当前位置:首页 - 行情中心 - 中国高科(600730) - 财务分析 - 现金流量表

中国高科

(600730)

  

流通市值:50.92亿  总市值:50.92亿
流通股本:5.87亿   总股本:5.87亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金51,685,599.6613,508,888.05153,091,667.2196,692,881.03
  收到其他与经营活动有关的现金13,035,002.595,560,318.5611,650,484.367,928,468.42
  经营活动现金流入小计64,720,602.2519,069,206.61164,742,151.57104,621,349.45
  购买商品、接受劳务支付的现金8,220,549.074,299,739.722,540,012.8316,374,882.36
  支付给职工以及为职工支付的现金37,505,674.8422,162,512.567,727,525.6452,563,765.93
  支付的各项税费16,463,450.0811,071,238.5716,633,317.2610,678,388.29
  支付其他与经营活动有关的现金15,546,485.458,216,991.9829,528,253.1721,907,812.29
  经营活动现金流出小计77,736,159.4445,750,482.75136,429,108.9101,524,848.87
  经营活动产生的现金流量净额-13,015,557.19-26,681,276.1428,313,042.673,096,500.58
二、投资活动产生的现金流量:
  收回投资收到的现金50,194,205.4628,700,0001,318,577,091.941,289,648,019.86
  取得投资收益收到的现金870,907.25500,952.628,570,679.7721,128,951.14
  处置固定资产、无形资产和其他长期资产收回的现金净额8,1438,14331,399.0731,399.07
  收到的其他与投资活动有关的现金---1
  投资活动现金流入小计51,073,255.7129,209,095.61,347,179,170.781,310,808,371.07
  购建固定资产、无形资产和其他长期资产支付的现金1,133,731.5138,5674,778,708.464,298,394.31
  投资支付的现金--737,200,000737,200,000
  支付其他与投资活动有关的现金--11,866,076.26-
  投资活动现金流出小计1,133,731.5138,567753,844,784.72741,498,394.31
  投资活动产生的现金流量净额49,939,524.2129,070,528.6593,334,386.06569,309,976.76
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金5,830,804.09-2,901,186.192,706,948.96
  其中:子公司支付给少数股东的股利、利润--2,901,186.192,706,948.96
  支付其他与筹资活动有关的现金1,938,422.48818,979.047,693,986.686,129,031.8
  筹资活动现金流出小计7,769,226.57818,979.0410,595,172.878,835,980.76
  筹资活动产生的现金流量净额-7,769,226.57-818,979.04-10,595,172.87-8,835,980.76
四、汇率变动对现金及现金等价物的影响-734.84-251.52,605.35-1,856.03
五、现金及现金等价物净增加额29,154,005.611,570,021.92611,054,861.21563,568,640.55
  加:期初现金及现金等价物余额1,017,384,615.671,017,384,615.67406,329,754.46406,329,754.46
  期末现金及现金等价物余额1,046,538,621.281,018,954,637.591,017,384,615.67969,898,395.01
补充资料:
  净利润-8,422,707.85-52,292,313.58-
  资产减值准备--42,958.51-
  固定资产和投资性房地产折旧344,448.93-758,173.03-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧344,448.93-758,173.03-
  无形资产摊销33,925.14-131,844.09-
  长期待摊费用摊销45,503.83-312,791.93-
  处置固定资产、无形资产和其他长期资产的损失29,700.79-66,754.19-
  固定资产报废损失19,321.87-8,611.76-
  公允价值变动损失-954,819.76-5,947,568.92-
  财务费用77,389.72-134,223.9-
  投资损失1,768,538.15--20,635,088.65-
  递延所得税-3,579.96--9,752,337.86-
  其中:递延所得税资产减少-3,603.92--4,764.59-
    递延所得税负债增加23.96--9,747,573.27-
  存货的减少595,148.34-1,482,322.85-
  经营性应收项目的减少-1,075,793.51--1,231,767.54-
  经营性应付项目的增加-11,469,415.85-4,742,185.58-
  其他3,398,860.57--7,910,166.85-
  现金的期末余额1,046,538,621.28-1,017,384,615.67-
  减:现金的期初余额1,017,384,615.67-406,329,754.46-
  现金及现金等价物的净增加额29,154,005.61-611,054,861.21-
公告日期2025-08-302025-04-302025-03-192024-10-31
审计意见(境内)标准无保留意见
TOP↑